Vinlon 1mg Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Vincristine (1mg)
Overview Vinlon 1mg Injection
Oncaspar 1mg Injection is a chemotherapy agent indicated for various cancers, including breast, non-small cell lung, pancreatic, renal, hematologic malignancies (such as multiple myeloma and lymphomas), and bone cancers. Administered intravenously under medical supervision, the dosage and frequency are determined individually by your oncologist based on your specific condition and may be adjusted. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse effects. While therapeutic benefits may take weeks or months to manifest, discontinuation should only occur under physician guidance. Common side effects include alopecia, peripheral neuropathy (numbness and tingling in extremities), and bowel irregularity. This medication can suppress blood cell production, increasing infection risk. Kidney complications linked to elevated uric acid are also possible. Regular blood tests monitoring blood cell counts, cardiac function, liver health, and uric acid levels are necessary. Inform your doctor of all other medications you are taking, as interactions may occur. Use during pregnancy or breastfeeding is contraindicated, and effective contraception for both partners is recommended. Avoid direct eye contact, as it can cause irritation.
Uses of Vinlon 1mg Injection
Cancers affecting the breast, lungs (non-small cell), pancreas, kidneys, blood (including multiple myeloma), lymphatic system, and bones.
Major Benefits of Vinlon 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Vinlon 1mg Injection:
- Hair loss
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Constipation
How to use Vinlon 1mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strongly discouraged.
How Vinlon 1mg Injection works:
Vinlon 1mg Injection inhibits the replication of DNA within cancerous cells, thereby halting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vinlon 1mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Vinlon 1mg Injection during pregnancy carries a confirmed risk to the fetus. Its use should be avoided except in rare, life-threatening circumstances where the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Vinlon 1mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from the medication.
DrivingUNSAFE
Administering Vinlon 1mg Injection may induce adverse reactions that could impair driving ability.
KidneyCAUTION
For individuals with kidney impairment, administering Vinlon 1mg Injection requires careful consideration. The dosage of Vinlon 1mg Injection might necessitate modification. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Vinlon 1mg Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Vinlon 1mg Injection :
NA
Facts to Know About Vinlon 1mg Injection
| Label | Value |
|---|---|
| Chemical Category | Vinca-derived anticancer agents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Vinca Alkaloid Antimitotic Agents |
3,018 People bought this recently